Portfolio company
Pretzel Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
Deep TechDigital Health
About
This biotechnology company develops small-molecule therapies for patients with mitochondrial dysfunction, including rare genetic conditions and common neurodegenerative diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.